Use of an Early Disease-Modifying Drug Adherence Measure to Predict Future Adherence in Patients with Multiple Sclerosis

por Kozma, Chris M., Phillips, Amy L., Meletiche, Dennis M.
Publicado 2014

Medication possession ratio: implications of using fixed and variable observation periods in assessing adherence with disease-modifying drugs in patients with multiple sclerosis

por Kozma, Chris M, Dickson, Michael, Phillips, Amy L, Meletiche, Dennis M
Publicado 2013

Treatment adherence and other patient-reported outcomes as cost determinants in multiple sclerosis: a review of the literature

por Lizán, Luis, Comellas, Marta, Paz, Silvia, Poveda, José Luis, Meletiche, Dennis M, Polanco, Carlos
Publicado 2014

Comparing the Cost-Effectiveness of Disease-Modifying Drugs for the First-Line Treatment of Relapsing-Remitting Multiple Sclerosis

por Goldberg, Lawrence, Edwards, Natalie C., Fincher, Contessa, Doan, Quan V., AL-Sabbagh, Ahmad, Meletiche, Dennis M.
Publicado 2009